These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19400225)

  • 1. A strategy for selectively shielding portions of a peptide/protein from immune response while maintaining immunogenicity of contiguous epitopes.
    Bianchi E; Finotto M; Ingallinella P; Citron M; Hrin R; Lu M; Geleziunas R; Miller MD; Liang X; Pessi A
    Adv Exp Med Biol; 2009; 611():359-60. PubMed ID: 19400225
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural mutants of HIV CTL epitopes with enhanced immunogenicity as potential vaccine candidates.
    Blondelle SE; Moya R; Schroder K; Osawa K; Wilson DB
    Adv Exp Med Biol; 2009; 611():379-82. PubMed ID: 19400233
    [No Abstract]   [Full Text] [Related]  

  • 3. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.
    Correia BE; Ban YE; Holmes MA; Xu H; Ellingson K; Kraft Z; Carrico C; Boni E; Sather DN; Zenobia C; Burke KY; Bradley-Hewitt T; Bruhn-Johannsen JF; Kalyuzhniy O; Baker D; Strong RK; Stamatatos L; Schief WR
    Structure; 2010 Sep; 18(9):1116-26. PubMed ID: 20826338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1.
    Lu Y; Xiao Y; Ding J; Dierich M; Chen YH
    Int Arch Allergy Immunol; 2000 Jan; 121(1):80-4. PubMed ID: 10686512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
    Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y
    J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene.
    Sun Z; Zhu Y; Wang Q; Ye L; Dai Y; Su S; Yu F; Ying T; Yang C; Jiang S; Lu L
    Emerg Microbes Infect; 2016 Jun; 5(6):e65. PubMed ID: 27329850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine design and the neutralizing antibody problem.
    Burton DR; Desrosiers RC; Doms RW; Koff WC; Kwong PD; Moore JP; Nabel GJ; Sodroski J; Wilson IA; Wyatt RT
    Nat Immunol; 2004 Mar; 5(3):233-6. PubMed ID: 14985706
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.
    Honda M; Matsuo K; Nakasone T; Okamoto Y; Yoshizaki H; Kitamura K; Sugiura W; Watanabe K; Fukushima Y; Haga S; Katsura Y; Tasaka H; Komuro K; Yamada T; Asano T; Yamazaki A; Yamazaki S
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10693-7. PubMed ID: 7479867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine design, immunogenicity and toxicity studies.
    Karpenko LI; Ilyichev AA; Eroshkin AM; Lebedev LR; Uzhachenko RV; Nekrasova NA; Plyasunova OA; Belavin PA; Seregin SV; Danilyuk NK; Zaitsev BN; Danilenko ED; Masycheva VI; Bazhan SI
    Vaccine; 2007 May; 25(21):4312-23. PubMed ID: 17418918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibody to Mengo virus, induced by synthetic peptides.
    Muir S; Weintraub JP; Hogle J; Bittle JL
    J Gen Virol; 1991 May; 72 ( Pt 5)():1087-92. PubMed ID: 1709682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.
    Xiao Y; Dong X; Chen Y
    Int Arch Allergy Immunol; 2000 Aug; 122(4):287-92. PubMed ID: 10971120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid immunization primes unique DTH responses to HIV-1MN envelope epitopes as compared to recombinant protein vaccination.
    Chattergoon MA; Maguire HH; Robinson TM; Serrano E; Boyer JD; Weiner DB
    Hybrid Hybridomics; 2002 Apr; 21(2):117-22. PubMed ID: 12031101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
    Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
    Zolla-Pazner S; Cohen SS; Krachmarov C; Wang S; Pinter A; Lu S
    Virology; 2008 Mar; 372(2):233-46. PubMed ID: 18061228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of multiple-pin peptide synthesis in an analysis of the continuous epitopes recognised by various anti-(recombinant bovine growth hormone) sera. Comparison with predicted regions of immunogenicity and location within the three-dimensional structure of the molecule.
    Beattie J; Fawcett HA; Flint DJ
    Eur J Biochem; 1992 Nov; 210(1):59-66. PubMed ID: 1280219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Different systems of delivery of HIV-1 DNA vaccine encoding the multiepitope CTL-immunogene].
    Il'ichev AA; Karpenko LI; Nekrasova NA; Lebedev LR; Ignat'ev GM; Agafonov AP; Belavin PA; Seregin SS; Daniliuk NK; Bazhan SI
    Vestn Ross Akad Med Nauk; 2005; (1):41-4. PubMed ID: 15715155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
    Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S
    Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.